Jeff Mc Leroy, MD
About Jeff Mc Leroy, MD
Jeff Mc Leroy, MD, serves as the Senior Director of Clinical Development at Instil Bio. He has extensive experience in patient safety and clinical roles, having previously held positions at Kite Pharma and Genentech.
Current Role at Instil Bio
Jeff Mc Leroy serves as the Senior Director of Clinical Development at Instil Bio. He has held this position since 2021 and is responsible for overseeing clinical development strategies and operations. His work focuses on advancing innovative therapies in the field of oncology, contributing to the company's mission of developing transformative cell therapies.
Previous Experience at Kite Pharma
Prior to his role at Instil Bio, Jeff Mc Leroy worked at Kite Pharma for a total of four years in various capacities related to patient safety. He started as Director of Patient Safety from 2016 to 2018, then advanced to Senior Director of Patient Safety from 2018 to 2020, and concluded his tenure as Executive Director of Patient Safety from 2020 to 2021. His experience at Kite Pharma involved ensuring the safety and efficacy of cell therapies.
Experience at Genentech
Jeff Mc Leroy began his career in safety roles at Genentech, where he worked from 2014 to 2016. He initially served as a Safety Scientist for nine months, followed by a position as Senior Safety Scientist for another nine months. His responsibilities included assessing safety data and contributing to the overall safety profile of Genentech's products.
Medical Training and Education
Jeff Mc Leroy completed his medical education at UC Davis School of Medicine, where he earned his Doctor of Medicine (M.D.) degree. He also completed a Fellowship in Hematology and Medical Oncology at the same institution. Prior to this, he underwent an Internal Medicine Residency Program at Kaiser Santa Clara Medical Center. His undergraduate studies were completed at the University of California, Berkeley, where he earned a Bachelor's Degree in Anthropology/Pre-Med.
Clinical Practice Background
Before transitioning to the pharmaceutical industry, Jeff Mc Leroy practiced as a Medical Oncologist/Hematologist at Kaiser Permanente from 2012 to 2014. In this role, he provided patient care and specialized treatment for individuals with cancer and blood disorders, gaining valuable clinical experience that informs his current work in clinical development.